Japan medicine information and human support for international patients.

AGA / hair loss medicine guide

Check Japanese hair-loss medicine names, ingredients, and package details before support review.

Use this guide to identify oral minoxidil, finasteride, dutasteride, topical minoxidil, and clinic-use AGA products by ingredient, form, amount printed on the package, and practical review details.

Common AGA product paths

Oral minoxidil

M Tablets

Japanese AGA materials list M Tablets in 1.25 mg, 2.5 mg, and 5.0 mg tablet formats. Requests should confirm the amount per tablet, tablet count, and cardiovascular safety context.

5-alpha reductase inhibitor

F Tablets

F Tablets contain finasteride in 1.3 mg and 3.0 mg formats in the available materials. Support needs the exact product name, tablet count, and handling caution context.

Dutasteride

Dutasteride 0.5 mg

CRM records show demand for dutasteride 0.5 mg products. The brand, manufacturer, package photo, and destination country should be confirmed before review.

Topical minoxidil

Minoxidil hair-growth liquid

Topical minoxidil products should be identified by concentration, bottle volume, number of bottles, and whether the product is positioned for men or women.

Topical gel

M/F HomeCare Gel

Available AGA materials include a 60 ml homecare gel format. Requests should include product photo, ingredient wording, bottle volume, and intended support question.

Clinic-use products

Mesona-J related products

ARA/D Active Powder, Active Booster M, and Base Solution appear in professional-use materials. These are better handled as clinic-use information checks, not simple consumer product lookups.

AGA product identification map

This table helps separate ingredient, form, and package wording. It is an information guide only and does not choose treatment or confirm availability.

Product pathIngredientFormPackage detail to confirmSupport note
M Tablets 1.25 / 2.5 / 5.0MinoxidilOral tabletsAmount per tablet, tablet count, bottle or box photoNeeds cardiovascular and current-medicine context.
F Tablets 1.3 / 3.0FinasterideOral tabletsAmount per tablet, tablet count, Japanese product wordingAdult male AGA context and handling cautions matter.
Dutasteride 0.5 mgDutasterideCapsule or tablet depending productBrand, manufacturer, amount per unit, package photoUseful CRM demand signal; exact identity must be checked.
Topical minoxidil liquidMinoxidilTopical solutionConcentration, bottle size, number of bottlesLocal irritation and product-positioning context can matter.
M/F HomeCare GelCombined topical AGA productTopical gel60 ml bottle, ingredient wording, product photoBest reviewed with exact source material.
ARA/D Active PowderAndrogen receptor antagonist plus 5-alpha reductase inhibitorClinic-use powderUse with Base Solution, preparation timing, professional-use contextNot a normal consumer medicine request.
Active Booster M / Base SolutionMinoxidil-related booster or base solutionClinic-use solutionVolume, set quantity, facility-use contextSupport should treat this as professional-use product information.

How to read AGA medicine information

Ingredient is not the same as brand

Minoxidil, finasteride, and dutasteride are ingredients. The product name, Japanese wording, manufacturer, tablet count, and package dose amount still need to be matched.

Oral and topical products have different questions

Oral tablets need current-medicine and safety context. Topical liquids need concentration, bottle size, and product-positioning details. Clinic-use products need professional-use context.

Japanese AGA materials may include unapproved-product notices

Some products may be physician-import or professional-information items rather than ordinary approved Japanese retail products. Support should verify the exact document and product route.

Destination-country rules still matter

Even when the product can be identified, the destination country, approximate quantity, and medicine category affect whether support can proceed.

AGA medicines can involve pregnancy-related handling cautions, cardiovascular concerns, sexual side effects, mood-related concerns, and interactions with current medicines. This page does not diagnose hair loss type, choose a dose, or replace medical advice.

Before contacting support

1

Name or photo

Send the product name or a clear package photo.

2

Ingredient

Minoxidil, finasteride, dutasteride, or topical product wording if known.

3

Package details

Amount printed on package, tablet count, bottle size, and quantity needed.

4

Destination

Destination country and whether the question is identity, comparison, or feasibility.

Ask support with complete AGA product details.

Send product name, ingredient, package dose amount, form, quantity, destination country, and a package photo if available.

Contact support

MedGuide Japan provides product-information support only. We do not diagnose, select treatments, replace medical advice, or guarantee availability.

Contact support